Experimental Hematology and Cancer Biology

Experimental Hematology Grants

Grant and Contract AwardsAnnual Direct

Akunuru, S

Training Programs in Cancer Therapeutics
T32 CA 11784609/14/12-08/31/14$48,435

Andreassen, P

14th Annual Midwest DNA Repair Symposium
R13 CA 16831704/01/12-03/31/13$6,000
FANCD2 Monoubiquitination in DNA Damage Responses
R01 HL 08558707/08/08-06/30/13$222,750

Cancelas-Perez, J

Rational Design of a Vav/Rac Inhibitor as a New Therapy
10/01/12-09/30/15$180,018

Choi, K

Regulation of Cellular Growth and Differentiation
T32 CA02062409/30/12-08/31/13$21,122

Degen, J

Analysis of Staphylococcus Aureus Host Interactions
R01 AI 02062409/30/10-08/31/13$49,971

Degen, J / Malik P (MPI)

Hemostatic Factors and Sickle Cell Disease
R01 HL 11260301/01/12-11/30/16$238,000

Feng, Y

Targeting Bone Marrow Niche to Eradicate Childhood Acute Myeloid Leukemia
06/01/13-05/31/14$25,000

Filippi, M

Regulation of Neutrophil Migration and Polarity
R01 HL 09067603/01/10-02/28/15$235,620

Flick, M

Mechanisms Linking the Hemostatic Protease Thrombin to Arthritic Disease
R01 AR 05699008/10/09-07/31/14$171,072
Cincinnati Rheumatic Disease Core Center (Core 2)
P30 AR 04736308/25/11-06/30/16$52,222

Geiger, H

Activated Protein C for Treatment of Radiation Combined Injury
R33 AI 08055709/13/10-08/31/13$77,488
Molecular Mechanisms and Therapies for Radiation-Induced Myelodysplastic Syndrome
04/01/12-03/31/17$181,818

Goyama, S

Suppressing a Tumor Suppressor RUNX1: A Novel Approach to Treat Pediatric Acute Leukemia
07/01/12-06/30/13$40,000

Hennigan, R

Regulation of Intracellular Trafficking in NF2
W81XWH131013606/01/13-05/31/16$129,421

Komurov, K

Targeting Metabolic Vulnerabilities of ERBB2-Driven Breast Cancer
04/01/13-03/31/14$40,000

Lin, S

Identification of Drug Development Pathway for Improving Prognosis of Pediatric Leukemia
05/01/12-04/30/13$30,000

Lutzko, C

NHLBI Progenitor Cell Biology Institute - Pilot Study
U01 HL 09999703/01/13-02/28/14$58,905

Malik, P

Ameliorating Sickle Nephropathy and Pulmonary Hypertension
R34 HL 10875208/18/11-06/30/14$150,000
Development of Safe and Efficient Gene Therapy Strategies
R01 HL 09848901/21/10-12/31/14$43,333
PLGF-H1F1a-mIRNA Axis in Sickle Pulmonary Hypertension
R01 HL 11137201/01/12-12/31/16$161,480
Cincinnati Cell Characterization Core
U01 HL 09999709/30/10-04/30/14$316,697
Cincinnati Cell Characterization Core - per assay
U01 HL 09999709/30/10-04/30/14$247,368

Mulloy, J

Genotype and Phenotype of Chemoresistant AML
R21 CA 16836903/01/13-02/28/15$130,500
Rac Signaling in MLL Leukemia
07/01/10-06/30/15$104,702

Olshavsky, N

Regulation of Cellular Growth and Differentiation
T32 CA 05926812/6/12-04/30/13$21,122

Pan, D

Genetic Therapy for CNS Manifestations in MPS I via BBB-Targeted Protein Delivery
R01 NS 06433009/30/08-08/31/13$214,375

Pang, Q

Role of FA Proteins in Hematopoiesis
R01 HL 07671204/01/10-03/31/15$235,620
Role of Tumor Necrosis Factor in Leukemogenesis
07/01/08-06/30/13$103,115
Targeted Improvement in Stem Cell Therapy for Leukemia and Bone Marrow Failure Syndromes
R01 CA 15753702/01/11-12/31/15$195,050

Patel, A

Neurofibromatosis Postdoctoral Traineeship
06/01/13-05/31/14$46,092

Ratner, N

Can Targeting Fat Cure MPNST?
06/01/13-05/31/14$30,000
Cincinnati Center for Neurofibromatosis Research
P50 NS 05753109/15/08-06/30/13$1,068,273
Ratner, NProject A$48,069
Cripe, TProject B$106,147
Rizvi, TProject C$81,328
Perentesis, JProject 1$297,056
Ratner, NProject 2$225,064
Ratner, NProject 3$276,814
Identification of Molecular and Cellular Contributors to Neurofibroma Formation and Growth
W81XWH121013307/01/12-06/30/15$221,965
In Vivo Testing of Anti-Oxidants in Nf1 CNS
07/01/12-06/30/13$45,455
Mitogenic Activities in Neurofibromatosis
R01 NS 02884009/15/11-07/31/16$231,250

Sampson, L

mTOR Signaling in Murine Intestinal Stem Cell and Progenitor Homeostasis
F32 DK 09787912/01/12-11/30/14$52,605

Starczynowski, D

Defining the Role and Therapeutic Potential of TNF Recep
06/01/13-05/31/16$68,182
Deregulation of TIFAB in Myelodysplastic Syndrome
07/01/11-06/30/14$50,000
Identification and Characterization of Genes in del(5q) Myelodysplastic Syndrome
R01 HL 11110312/15/11-11/30/16$238,000
Regulation and Function of TIFAB in Myelodysplastic Synd
W81XWH111046806/01/11-05/31/14$132,295

Tandon, P

Training Programs in Cancer Therapeutics
T32 CA 11784609/14/12-08/31/14$48,435

Varney, M

Environmental Carcinogenesis and Mutagenesis
T32 ES 00725005/01/12-04/30/14$6,894

Wu, J

STAT3 in Neurofibroma Tumorigenesis and Therapy
W81XWH111025907/01/11-06/30/14$132,862
Exploring the Plexiform Neurofibroma Interactone
05/15/13-05/14/15$292,910

Zheng, Y

Cincinnati Center for Excellence in Molecular Hematology
P30 DK 09097107/01/10-06/30/13$505,315
Zheng, YAdmin Core$91,497
Grabowski, GGenomics and Genetic Core$63,001
Cancelas, JCell Analysis and Sorting Core$65,112
Malik, PTranslational Core$163,824
Mulloy, JXenotransplant and Transgenic Core$68,765
Zheng, YSummer Students$30,370
Pharmacological Rejuvenation of Aged Hematopoietic Stem Cells
R34 AG 04298608/15/12-07/31/13$84,870
Rac GTPase-Specific Small Molecular Inhibitors
R01 CA 14134103/24/09-01/31/14$151,943
Training Program in Pediatric Hematologic and Oncologic Diseases
T32 HL 09180509/01/08-08/31/13$155,456
Digestive Health Center: Bench to Bedside Pilot Study
P30 DK 07839206/01/13-05/31/14$50,000

Zheng, Y / Mulloy, J

Targeting Cdc42 in Leukemia Stem Cells
R01 CA 15054703/10/10-01/31/15$189,199

Zheng,Y/ Geiger, H

Lineage Determination and Tissue HomeOstasis in the Aged Hematopoietic System
R01 AG 04011808/01/11-07/31/16$250,000
Current Year Direct$7,783,205
Industry Contracts

Mulloy, J

$164,254
$8,916
$37,668

Grassman, E

$63,176
Current Year Direct Receipts$274,014
Total$8,057,219